First Time Loading...

Masimo Corp
NASDAQ:MASI

Watchlist Manager
Masimo Corp Logo
Masimo Corp
NASDAQ:MASI
Watchlist
Price: 136.14 USD 0.67% Market Closed
Updated: Apr 27, 2024

Gross Margin
Masimo Corp

49%
Current
58%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
49%
=
Gross Profit
1B
/
Revenue
2B

Gross Margin Across Competitors

Gross Margin Comparison
Masimo Corp Competitors

Country Company Market Cap Gross
Margin
US
Masimo Corp
NASDAQ:MASI
7.2B USD
49%
US
Abbott Laboratories
NYSE:ABT
186.5B USD
55%
US
Intuitive Surgical Inc
NASDAQ:ISRG
133.1B USD
66%
US
Stryker Corp
NYSE:SYK
127.6B USD
64%
US
Boston Scientific Corp
NYSE:BSX
107.2B USD
70%
IE
Medtronic PLC
NYSE:MDT
106B USD
66%
US
Becton Dickinson and Co
NYSE:BDX
66.9B USD
41%
DE
Siemens Healthineers AG
XETRA:SHL
59.1B EUR
36%
US
Edwards Lifesciences Corp
NYSE:EW
52B USD
77%
US
Dexcom Inc
NASDAQ:DXCM
47.9B USD
64%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
349.3B CNY
65%
Masimo Corp
NASDAQ:MASI
Country US
Market Cap 7.2B USD
Gross Margin
49%
Abbott Laboratories
NYSE:ABT
Country US
Market Cap 186.5B USD
Gross Margin
55%
Intuitive Surgical Inc
NASDAQ:ISRG
Country US
Market Cap 133.1B USD
Gross Margin
66%
Stryker Corp
NYSE:SYK
Country US
Market Cap 127.6B USD
Gross Margin
64%
Boston Scientific Corp
NYSE:BSX
Country US
Market Cap 107.2B USD
Gross Margin
70%
Medtronic PLC
NYSE:MDT
Country IE
Market Cap 106B USD
Gross Margin
66%
Becton Dickinson and Co
NYSE:BDX
Country US
Market Cap 66.9B USD
Gross Margin
41%
Siemens Healthineers AG
XETRA:SHL
Country DE
Market Cap 59.1B EUR
Gross Margin
36%
Edwards Lifesciences Corp
NYSE:EW
Country US
Market Cap 52B USD
Gross Margin
77%
Dexcom Inc
NASDAQ:DXCM
Country US
Market Cap 47.9B USD
Gross Margin
64%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Country CN
Market Cap 349.3B CNY
Gross Margin
65%

Profitability Report

View the profitability report to see the full profitability analysis for Masimo Corp.

Full Profitability Report

See Also

Summary
MASI intrinsic value, competitors valuation, and company profile.
DCF Valuation
MASI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MASI stock valuation using valuation multiples.
Wall Street Estimates
MASI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MASI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
49%
=
Gross Profit
1B
/
Revenue
2B
What is the Gross Margin of Masimo Corp?

Based on Masimo Corp's most recent financial statements, the company has Gross Margin of 49%.

ALPHA SPREAD
Join more than 131,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.